annual retained earnings:
$9.61B-$535.60M(-5.28%)Summary
- As of today (May 1, 2025), VRTX annual retained earnings is $9.61 billion, with the most recent change of -$535.60 million (-5.28%) on December 31, 2024.
- During the last 3 years, VRTX annual retained earnings has risen by +$6.41 billion (+200.14%).
- VRTX annual retained earnings is now -5.28% below its all-time high of $10.14 billion, reached on December 31, 2023.
Performance
VRTX Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
$9.61B+$913.00M(+10.50%)Summary
- As of today (May 1, 2025), VRTX quarterly retained earnings is $9.61 billion, with the most recent change of +$913.00 million (+10.50%) on December 31, 2024.
- Over the past year, VRTX quarterly retained earnings has dropped by -$535.60 million (-5.28%).
- VRTX quarterly retained earnings is now -14.55% below its all-time high of $11.24 billion, reached on March 31, 2024.
Performance
VRTX quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
VRTX Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.3% | -5.3% |
| 3 y3 years | +200.1% | +68.4% |
| 5 y5 years | +618.5% | +68.4% |
VRTX Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.3% | +200.1% | -14.6% | +142.4% |
| 5 y | 5-year | -5.3% | +618.5% | -14.6% | +868.4% |
| alltime | all time | -5.3% | +278.8% | -14.6% | +277.7% |
Vertex Pharmaceuticals Incorporated Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $9.61B(-5.3%) | $9.61B(+10.5%) |
| Sep 2024 | - | $8.69B(+13.7%) |
| Jun 2024 | - | $7.65B(-32.0%) |
| Mar 2024 | - | $11.24B(+10.8%) |
| Dec 2023 | $10.14B(+55.5%) | $10.14B(+10.6%) |
| Sep 2023 | - | $9.17B(+12.7%) |
| Jun 2023 | - | $8.14B(+12.7%) |
| Mar 2023 | - | $7.22B(+10.7%) |
| Dec 2022 | $6.52B(+103.8%) | $6.52B(+14.4%) |
| Sep 2022 | - | $5.70B(+19.5%) |
| Jun 2022 | - | $4.77B(+20.5%) |
| Mar 2022 | - | $3.96B(+23.8%) |
| Dec 2021 | $3.20B(+272.7%) | $3.20B(+31.7%) |
| Sep 2021 | - | $2.43B(+54.0%) |
| Jun 2021 | - | $1.58B(+4.4%) |
| Mar 2021 | - | $1.51B(+76.1%) |
| Dec 2020 | $858.70M(-146.3%) | $858.70M(+237.4%) |
| Sep 2020 | - | $254.48M(-161.6%) |
| Jun 2020 | - | -$412.95M(-67.0%) |
| Mar 2020 | - | -$1.25B(-32.5%) |
| Dec 2019 | -$1.85B(-38.0%) | -$1.85B(-23.9%) |
| Sep 2019 | - | -$2.44B(-2.3%) |
| Jun 2019 | - | -$2.49B(-9.7%) |
| Mar 2019 | - | -$2.76B(-7.6%) |
| Dec 2018 | -$2.99B(-41.6%) | -$2.99B(-34.2%) |
| Sep 2018 | - | -$4.54B(-2.8%) |
| Jun 2018 | - | -$4.67B(-4.3%) |
| Mar 2018 | - | -$4.88B(-4.8%) |
| Dec 2017 | -$5.12B(-4.7%) | -$5.12B(-1.9%) |
| Sep 2017 | - | -$5.22B(+2.0%) |
| Jun 2017 | - | -$5.12B(-0.4%) |
| Mar 2017 | - | -$5.14B(-4.4%) |
| Dec 2016 | -$5.37B(+2.1%) | -$5.37B(-0.6%) |
| Sep 2016 | - | -$5.41B(+0.7%) |
| Jun 2016 | - | -$5.37B(+1.2%) |
| Mar 2016 | - | -$5.30B(+0.8%) |
| Dec 2015 | -$5.26B(+11.8%) | -$5.26B(+1.4%) |
| Sep 2015 | - | -$5.19B(+1.9%) |
| Jun 2015 | - | -$5.09B(+3.9%) |
| Mar 2015 | - | -$4.90B(+4.2%) |
| Dec 2014 | -$4.71B(+18.6%) | -$4.71B(+3.9%) |
| Sep 2014 | - | -$4.53B(+3.9%) |
| Jun 2014 | - | -$4.36B(+3.8%) |
| Mar 2014 | - | -$4.20B(+5.9%) |
| Dec 2013 | -$3.97B(+12.6%) | -$3.97B(-1.1%) |
| Sep 2013 | - | -$4.01B(+3.2%) |
| Jun 2013 | - | -$3.89B(+1.5%) |
| Mar 2013 | - | -$3.83B(+8.7%) |
| Dec 2012 | -$3.52B(+3.1%) | -$3.52B(+2.2%) |
| Sep 2012 | - | -$3.45B(+1.7%) |
| Jun 2012 | - | -$3.39B(+2.0%) |
| Mar 2012 | - | -$3.32B(-2.7%) |
| Dec 2011 | -$3.41B(-0.9%) | -$3.41B(-4.4%) |
| Sep 2011 | - | -$3.57B(-5.8%) |
| Jun 2011 | - | -$3.79B(+4.8%) |
| Mar 2011 | - | -$3.62B(+5.1%) |
| Dec 2010 | -$3.44B(+28.1%) | -$3.44B(+5.5%) |
| Sep 2010 | - | -$3.26B(+6.8%) |
| Jun 2010 | - | -$3.06B(+7.0%) |
| Mar 2010 | - | -$2.86B(+6.1%) |
| Dec 2009 | -$2.69B(+31.4%) | -$2.69B(+6.3%) |
| Sep 2009 | - | -$2.53B(+6.3%) |
| Jun 2009 | - | -$2.38B(+7.8%) |
| Mar 2009 | - | -$2.21B(+7.9%) |
| Dec 2008 | -$2.05B(+29.0%) | -$2.05B(+7.5%) |
| Sep 2008 | - | -$1.91B(+7.3%) |
| Jun 2008 | - | -$1.78B(+5.4%) |
| Mar 2008 | - | -$1.68B(+6.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | -$1.59B(+32.7%) | -$1.59B(+5.7%) |
| Sep 2007 | - | -$1.50B(+7.7%) |
| Jun 2007 | - | -$1.39B(+9.2%) |
| Mar 2007 | - | -$1.28B(+6.7%) |
| Dec 2006 | -$1.20B(+20.9%) | -$1.20B(+2.3%) |
| Sep 2006 | - | -$1.17B(+4.6%) |
| Jun 2006 | - | -$1.12B(+7.5%) |
| Mar 2006 | - | -$1.04B(+5.1%) |
| Dec 2005 | -$989.58M(+25.9%) | -$989.58M(+4.0%) |
| Sep 2005 | - | -$951.45M(+9.1%) |
| Jun 2005 | - | -$871.88M(+4.9%) |
| Mar 2005 | - | -$830.89M(+5.7%) |
| Dec 2004 | -$786.17M(+26.8%) | -$786.17M(+5.8%) |
| Sep 2004 | - | -$743.40M(+5.5%) |
| Jun 2004 | - | -$704.63M(+6.7%) |
| Mar 2004 | - | -$660.36M(+6.5%) |
| Dec 2003 | -$619.92M(+46.5%) | -$619.92M(+7.1%) |
| Sep 2003 | - | -$578.89M(+17.5%) |
| Jun 2003 | - | -$492.47M(+22.3%) |
| Mar 2003 | - | -$402.54M(-4.9%) |
| Dec 2002 | -$423.15M(+34.5%) | -$423.15M(+8.2%) |
| Sep 2002 | - | -$391.07M(+9.4%) |
| Jun 2002 | - | -$357.62M(+6.2%) |
| Mar 2002 | - | -$336.60M(+7.0%) |
| Dec 2001 | -$314.53M(+26.7%) | -$314.53M(+1.0%) |
| Sep 2001 | - | -$311.27M(+23.8%) |
| Jun 2001 | - | -$251.46M(+5.1%) |
| Mar 2001 | - | -$239.35M(-3.6%) |
| Dec 2000 | -$248.30M(+30.1%) | -$248.30M(+13.3%) |
| Sep 2000 | - | -$219.23M(+12.8%) |
| Jun 2000 | - | -$194.37M(-6.1%) |
| Mar 2000 | - | -$206.99M(+8.5%) |
| Dec 1999 | -$190.83M(+27.3%) | -$190.83M(-0.9%) |
| Sep 1999 | - | -$192.50M(+8.0%) |
| Jun 1999 | - | -$178.30M(+6.5%) |
| Mar 1999 | - | -$167.40M(+11.7%) |
| Dec 1998 | -$149.90M(+28.3%) | -$149.90M(+9.2%) |
| Sep 1998 | - | -$137.30M(+1.7%) |
| Jun 1998 | - | -$135.00M(+7.8%) |
| Mar 1998 | - | -$125.20M(+7.2%) |
| Dec 1997 | -$116.80M(+20.5%) | -$116.80M(+6.2%) |
| Sep 1997 | - | -$110.00M(+5.7%) |
| Jun 1997 | - | -$104.10M(+1.4%) |
| Mar 1997 | - | -$102.70M(+6.0%) |
| Dec 1996 | -$96.90M(+70.3%) | -$96.90M(+4.1%) |
| Sep 1996 | - | -$93.10M(+7.4%) |
| Jun 1996 | - | -$86.70M(+34.6%) |
| Mar 1996 | - | -$64.40M(+13.2%) |
| Dec 1995 | -$56.90M(+60.7%) | -$56.90M(+1.4%) |
| Sep 1995 | - | -$56.10M(+14.3%) |
| Jun 1995 | - | -$49.10M(+22.4%) |
| Mar 1995 | - | -$40.10M(+13.3%) |
| Dec 1994 | -$35.40M(+98.9%) | -$35.40M(+16.1%) |
| Sep 1994 | - | -$30.50M(+14.7%) |
| Jun 1994 | - | -$26.60M(+26.1%) |
| Mar 1994 | - | -$21.10M(+18.5%) |
| Dec 1993 | -$17.80M(-10.6%) | -$17.80M(-33.1%) |
| Sep 1993 | - | -$26.60M(+11.3%) |
| Jun 1993 | - | -$23.90M(+3.0%) |
| Mar 1993 | - | -$23.20M(+16.6%) |
| Dec 1992 | -$19.90M(+74.6%) | -$19.90M(+15.7%) |
| Sep 1992 | - | -$17.20M(+15.4%) |
| Jun 1992 | - | -$14.90M(+14.6%) |
| Mar 1992 | - | -$13.00M(+14.0%) |
| Dec 1991 | -$11.40M(+83.9%) | -$11.40M(+14.0%) |
| Sep 1991 | - | -$10.00M(+13.6%) |
| Jun 1991 | - | -$8.80M(+41.9%) |
| Dec 1990 | -$6.20M | -$6.20M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual retained earnings?
- What is the all time high annual retained earnings for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual retained earnings year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly retained earnings?
- What is the all time high quarterly retained earnings for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly retained earnings year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual retained earnings?
The current annual retained earnings of VRTX is $9.61B
What is the all time high annual retained earnings for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual retained earnings is $10.14B
What is Vertex Pharmaceuticals Incorporated annual retained earnings year-on-year change?
Over the past year, VRTX annual retained earnings has changed by -$535.60M (-5.28%)
What is Vertex Pharmaceuticals Incorporated quarterly retained earnings?
The current quarterly retained earnings of VRTX is $9.61B
What is the all time high quarterly retained earnings for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly retained earnings is $11.24B
What is Vertex Pharmaceuticals Incorporated quarterly retained earnings year-on-year change?
Over the past year, VRTX quarterly retained earnings has changed by -$535.60M (-5.28%)